Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Enlivex Ltd banner

Enlivex Ltd
SWB:1BT

Watchlist Manager
Enlivex Ltd Logo
Enlivex Ltd
SWB:1BT
Watchlist
Price: 0.15 EUR -2.6% Market Closed
Market Cap: €13.5m
Write Note Create Alert

Intrinsic Value

Not Available for 1BT

There is not enough data to reliably calculate the intrinsic value for Enlivex Ltd.

Do our valuations actually work? See backtest results .

Alternatives to 1BT

Fundamental Analysis

What Enlivex Does

Biotechnology Health Care

Enlivex Therapeutics is a clinical-stage biotechnology company that develops cell-based therapies for severe inflammatory diseases. Its main program is built around a treatment called Allocetra, which uses immune cells to help reset an overactive immune response. The company is trying to turn this approach into medicines for conditions where the body’s own inflammation becomes harmful, such as sepsis and other acute disorders.

Headquarters
Israel IL
Employees
34
IPO date
Jul 30, 2014
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Enlivex Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue 1BT Research

Summary
1BT intrinsic value, competitors valuation, and company profile.
DCF Valuation
1BT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
1BT stock valuation using valuation multiples.
Wall St Estimates
1BT price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
1BT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Enlivex Ltd listings:
NASDAQ • USD
ENLV
 F • EUR
1BT
Discover More
ALPHA SPREAD
Follow us
Join 362,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.